These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16573813)
21. Treatment with human chorionic gonadotropin for PADAM: a preliminary report. Tsujimura A; Matsumiya K; Takao T; Miyagawa Y; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A Aging Male; 2005; 8(3-4):175-9. PubMed ID: 16390742 [TBL] [Abstract][Full Text] [Related]
22. Aging Males' Symptoms scale in Japanese men attending a multiphasic health screening clinic. Ichioka K; Nishiyama H; Yoshimura K; Itoh N; Okubo K; Terai A Urology; 2006 Mar; 67(3):589-93. PubMed ID: 16504258 [TBL] [Abstract][Full Text] [Related]
23. Aging Male Questionnaire in normal and complaining men. Raynaud JP; Tichet J; Born C; Taieb C; Igigabel P; Giton F; Fiet J J Sex Med; 2008 Nov; 5(11):2703-12. PubMed ID: 18637991 [TBL] [Abstract][Full Text] [Related]
24. Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy. Taniguchi H; Kawa G; Kinoshita H; Matsuda T Aging Male; 2011 Sep; 14(3):190-4. PubMed ID: 21557686 [TBL] [Abstract][Full Text] [Related]
25. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men. Fennell C; Sartorius G; Ly LP; Turner L; Liu PY; Conway AJ; Handelsman DJ Clin Endocrinol (Oxf); 2010 Jul; 73(1):102-9. PubMed ID: 19891698 [TBL] [Abstract][Full Text] [Related]
26. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy. McGill JJ; Shoskes DA; Sabanegh ES Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330 [TBL] [Abstract][Full Text] [Related]
27. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Boyanov MA; Boneva Z; Christov VG Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074 [TBL] [Abstract][Full Text] [Related]
28. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. Behre HM; Heinemann L; Morales A; Pexman-Fieth C Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063 [TBL] [Abstract][Full Text] [Related]
29. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. T'Sjoen G; Goemaere S; De Meyere M; Kaufman JM Psychoneuroendocrinology; 2004 Feb; 29(2):201-14. PubMed ID: 14604601 [TBL] [Abstract][Full Text] [Related]
30. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism. Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383 [TBL] [Abstract][Full Text] [Related]
31. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients]. Taniguchi H; Kawa G; Kinoshita H; Matsuda T Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556 [TBL] [Abstract][Full Text] [Related]
32. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542 [TBL] [Abstract][Full Text] [Related]
33. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
34. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings. Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428 [TBL] [Abstract][Full Text] [Related]
35. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Heinemann LA; Saad F; Heinemann K; Thai DM Aging Male; 2004 Sep; 7(3):211-8. PubMed ID: 15669540 [TBL] [Abstract][Full Text] [Related]
36. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215 [TBL] [Abstract][Full Text] [Related]
37. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Emmelot-Vonk MH; Verhaar HJ; Nakhai-Pour HR; Grobbee DE; van der Schouw YT Clin Endocrinol (Oxf); 2011 Apr; 74(4):488-94. PubMed ID: 21138462 [TBL] [Abstract][Full Text] [Related]
38. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity]. Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765 [TBL] [Abstract][Full Text] [Related]
39. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. Daniell HW; Lentz R; Mazer NA J Pain; 2006 Mar; 7(3):200-10. PubMed ID: 16516826 [TBL] [Abstract][Full Text] [Related]